Saag MS - Search Results

1

Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.

Crane HM, Grunfeld C, Willig JH, Mugavero MJ, Van Rompaey S, Moore R, Rodriguez B, Feldman BJ, Lederman MM, Saag MS, Kitahata MM. Crane HM, et al. Among authors: saag ms. AIDS. 2011 Jan 14;25(2):185-95. doi: 10.1097/QAD.0b013e328341f925. AIDS. 2011. PMID: 21150555 Free PMC article.

2

Predictors of optimal virological response to potent antiretroviral therapy.

Powderly WG, Saag MS, Chapman S, Yu G, Quart B, Clendeninn NJ. Powderly WG, et al. Among authors: saag ms. AIDS. 1999 Oct 1;13(14):1873-80. doi: 10.1097/00002030-199910010-00009. AIDS. 1999. PMID: 10513645

3

To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.

Coombs R, Cotton D, Hammer S, Saag M, van der Horst C. Coombs R, et al. AIDS Clin Care. 1996 Jan;8(1):1-4. AIDS Clin Care. 1996. PMID: 11363056

4

The impact of highly active antiretroviral therapy on HIV-specific immune function.

Saag MS. Saag MS. AIDS. 2001 Feb;15 Suppl 2:S4-10. doi: 10.1097/00002030-200102002-00002. AIDS. 2001. PMID: 11424976 Review.

5

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, Anderson R, Clendeninn N; Virqacept Collaborative Study Group. Saag MS, et al. AIDS. 2001 Oct 19;15(15):1971-8. doi: 10.1097/00002030-200110190-00009. AIDS. 2001. PMID: 11600825 Clinical Trial.

6

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS; International AIDS Society-USA. Schambelan M, et al. Among authors: saag ms. J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):257-75. doi: 10.1097/00126334-200211010-00001. J Acquir Immune Defic Syndr. 2002. PMID: 12439201 Review.

7

Duration of highly active antiretroviral therapy regimens.

Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Saag MS. Chen RY, et al. Among authors: saag ms. Clin Infect Dis. 2003 Sep 1;37(5):714-22. doi: 10.1086/377271. Epub 2003 Aug 13. Clin Infect Dis. 2003. PMID: 12942406

8

Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients.

Kotler DP, Muurahainen N, Grunfeld C, Wanke C, Thompson M, Saag M, Bock D, Simons G, Gertner JM; Serostim in Adipose Redistribution Syndrome Study Group. Kotler DP, et al. J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):239-52. doi: 10.1097/00126334-200403010-00004. J Acquir Immune Defic Syndr. 2004. PMID: 15076238 Clinical Trial.

9

Fat distribution in men with HIV infection.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Bacchetti P, et al. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):121-31. doi: 10.1097/01.qai.0000182230.47819.aa. J Acquir Immune Defic Syndr. 2005. PMID: 16186728 Free PMC article.

10

Distribution of health care expenditures for HIV-infected patients.

Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Chen RY, et al. Among authors: saag ms. Clin Infect Dis. 2006 Apr 1;42(7):1003-10. doi: 10.1086/500453. Epub 2006 Feb 22. Clin Infect Dis. 2006. PMID: 16511767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page